© 2005-2012 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.
This year, an estimated 49,560 women in the United States will be diagnosed with uterine endometrial cancer. It is estimated that 8,190 deaths from this disease will occur this year. Uterine cancer is the fourth most common cancer and the eighth most common cause of cancer death for women in the United States. Although uterine cancer rates are higher among white women than black women, black women are more likely to die from uterine cancer than white women.
The one-year relative survival rate (percentage of people who survive at least one year after the cancer is detected, excluding those who die from other diseases) for uterine cancer is 92%. The five-year survival rate for a woman with a local (without spread) uterine cancer at diagnosis is about 95%. If the cancer is diagnosed with regional spread, the five-year survival rate is about 67%, and if diagnosed after the cancer has spread more distantly, it is 16%.
Cancer survival statistics should be interpreted with caution. These estimates are based on data from thousands of people with this type of cancer in the United States each year, but the actual risk for a particular individual may differ. It is not possible to tell a woman how long she will live with uterine cancer. Because the survival statistics are measured in multi-year intervals, they may not represent advances made in the treatment or diagnosis of this cancer. Learn more about understanding statistics.
Statistics adapted from the American Cancer Society's publication, Cancer Facts & Figures 2013.